[go: up one dir, main page]

EP3846813A4 - Compositions analgésiques - Google Patents

Compositions analgésiques Download PDF

Info

Publication number
EP3846813A4
EP3846813A4 EP19858445.0A EP19858445A EP3846813A4 EP 3846813 A4 EP3846813 A4 EP 3846813A4 EP 19858445 A EP19858445 A EP 19858445A EP 3846813 A4 EP3846813 A4 EP 3846813A4
Authority
EP
European Patent Office
Prior art keywords
analgesic compositions
analgesic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19858445.0A
Other languages
German (de)
English (en)
Other versions
EP3846813A1 (fr
Inventor
Boris Tabakoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lohocla Research Corp
Original Assignee
Lohocla Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/125,252 external-priority patent/US10391088B2/en
Application filed by Lohocla Research Corp filed Critical Lohocla Research Corp
Publication of EP3846813A1 publication Critical patent/EP3846813A1/fr
Publication of EP3846813A4 publication Critical patent/EP3846813A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP19858445.0A 2018-09-07 2019-09-04 Compositions analgésiques Pending EP3846813A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/125,252 US10391088B2 (en) 2014-06-20 2018-09-07 Analgesic compositions
PCT/US2019/049457 WO2020051182A1 (fr) 2018-09-07 2019-09-04 Compositions analgésiques

Publications (2)

Publication Number Publication Date
EP3846813A1 EP3846813A1 (fr) 2021-07-14
EP3846813A4 true EP3846813A4 (fr) 2022-06-01

Family

ID=69722588

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19858445.0A Pending EP3846813A4 (fr) 2018-09-07 2019-09-04 Compositions analgésiques

Country Status (3)

Country Link
EP (1) EP3846813A4 (fr)
JP (1) JP7406266B2 (fr)
WO (1) WO2020051182A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070087977A1 (en) * 2004-11-16 2007-04-19 Wendye Robbins Methods and compositions for treating pain
WO2015195943A1 (fr) * 2014-06-20 2015-12-23 Lohocla Research Corporation Agents thérapeutiques multifonctionnels à base d'aminoquinoline

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009067703A2 (fr) * 2007-11-23 2009-05-28 Nectid, Inc. Compositions de tapentadol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070087977A1 (en) * 2004-11-16 2007-04-19 Wendye Robbins Methods and compositions for treating pain
WO2015195943A1 (fr) * 2014-06-20 2015-12-23 Lohocla Research Corporation Agents thérapeutiques multifonctionnels à base d'aminoquinoline

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020051182A1 *

Also Published As

Publication number Publication date
EP3846813A1 (fr) 2021-07-14
WO2020051182A1 (fr) 2020-03-12
JP2022501419A (ja) 2022-01-06
JP7406266B2 (ja) 2023-12-27

Similar Documents

Publication Publication Date Title
EP3722358A4 (fr) Composition
DK3697376T3 (da) Sammensætning
EP3534968A4 (fr) Compositions de lymphocytes t car anti-bcma
DK3924443T3 (da) Compositions
DK3655038T3 (da) Farmaceutisk sammensætning
EP4125815A4 (fr) Compositions thérapeutiques
EP3871694A4 (fr) Composition
DK3840596T3 (da) Sammensætning
EP4234657C0 (fr) Compositions
EP3713416C0 (fr) Compositions fongicides
EP3746043A4 (fr) Compositions topiques
EP4079787A4 (fr) Composition durcissable
EP3981256A4 (fr) Composition
EP3829538C0 (fr) Composition topique
DK3583943T3 (da) Farmaceutisk sammensætning
PT3765379T (pt) Composições
EP3864058A4 (fr) Composition photodurcissable
EP3941942A4 (fr) Composition
DK3528791T3 (da) Dispergible sammensætninger
EP3769784A4 (fr) Composition de suppression de l'inflammation
EP4079788A4 (fr) Composition durcissable
SMT202400478T1 (it) Composizione farmaceutica
EP3954721A4 (fr) Composition
EP3829532A4 (fr) Compositions de kératine
EP3883536A4 (fr) Compositions autobronzantes améliorées

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210312

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40057648

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20220502

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 215/48 20060101ALI20220425BHEP

Ipc: C07D 215/46 20060101ALI20220425BHEP

Ipc: A61K 31/4706 20060101AFI20220425BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250415

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LOHOCLA RESEARCH CORPORATION